1Workowski KA, Bolan GA (2015) Sexually transmitted diseases treatment guidelines, Centers for Disease Control and Prevention.

2Gardella C, Eckert LO, Lentz GM (2017) Genital tract infections. In: Comprehensive Gynecology, 7th ed, Lobo RA, Gershenson DM, Lentz GM, Valea FA (Eds), Elsevier, Philadelphia 542.

3Ozcan SK, Budak F, Yucesoy G, Susever S, et al. (2006) Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. APMIS 114139-145

4Paulitsch A, Weger W, Ginter-Hanselmayer G, Marth E, et al. ( 2006) A 5-year (2000-2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria. Mycoses 49:471-475.

5Vermitsky JP, Self MJ, Chadwick SG, Trama JP, et al. (2008) Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection. J Clin Microbiol. 46:1501-1503.

6Goswami D, Goswami R, Banerjee U, Dadhwal V, et al. (2006) Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole. J. Infect. 52111-117.

7Trama JP, Adelson ME , Raphaelli I, Stemmer SM, et al. ( 2005) Detection of Candida species in vaginal samples in a clinical laboratory setting. Dis Obstet Gynecol 13: 63–67.

8Richter SS, Galask RP , Messer SA, Hollis RJ, et al. ( 2005) Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases. J Clin Micro biol 43: 2155–2162.

9Nyirjesy P, Seeney SM, Grody MH, Jordan CA, et al. (1995) Chronic fungal vaginitis: the value of cultures. Am. J. Obstet. Gynecol 173:820-823.

10Berkow EL, and Lockhart SR (2017) Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist 10: 237–245.

11Workowski KA, Bolan GA (2015) Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015.MMWR Recomm Rep 64(RR-03):1.

12ISSVD app, April 2016

13Nurbhai M, Grimshaw J, Watson M, Bond C, et al. (2007) Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 17:CD002845.

14Sobel JD (2013) Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis. DovePress 16. doi: 10.2147/PPA.S38984.PMCID: PMC3869914 PMID: 24368881

15https://www.pfizermedicalinformation.com/en-us/diflucan/warnings

16Mølgaard-Nielsen D, Svanström H, Melbye M, Hviid A, Pasternak B (2016) Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA. 315:58.

17Geiger AM, Foxman B, Gillespie BW (1995) The epidemiology of vulvovaginal candidiasis among university students. Am J Public Health 85:1146.

18Foxman B, Muraglia R, Dietz JP, Sobel JD, et al. (2013) Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genital Tract Dis 17:340.

19Giraldo PC, Polpeta NC, Juliato CR, Yoshida LP, et al. (2012) Evaluation of sexual function in Brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia. J Sex Med 9:805-811.